× Didn't find what you were looking for? Ask a question
Top Posters
Since Sunday
y
2
m
2
m
2
u
2
m
2
B
2
M
2
e
2
k
2
N
2
y
2
m
2
New Topic  
gaoxing01 gaoxing01
wrote...
Posts: 301
Rep: 0 0
6 years ago
The FDA issued a safety announcement regarding the use of erythropoiesis-stimulating agents (ESAs) in 2010 with the recommendation that:
 
  1. ESAs no longer be prescribed to patients with chronic renal failure
  2. The risk of tumor development be explained to cancer patients on ESA therapy
  3. Patients should no longer receive ESA therapy to prepare for allogenic transfusions
  4. ESAs be prescribed only to patients younger than age 60 years
 
  ___
Read 32 times
1 Reply

Related Topics

Replies
wrote...
6 years ago
2
New Topic      
Explore
Post your homework questions and get free online help from our incredible volunteers
  696 People Browsing
Related Images
  
 379
  
 40
  
 355
Your Opinion
What percentage of nature vs. nurture dictates human intelligence?
Votes: 437